Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?

Clinical Nephrology

Volumn 53, Issue SUPPL. 1, 2000, Pages

  Sommerburg, O ^a   Grune, T ^b   Hampl, H ^c   Riedel, E ^d   Ehrich, J H H ^c   Siems, W G ^e,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Physical Medicine and Rehabilitation ^*

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f Herzog Julius Klinik GmbH & Co KG   (Germany)

Author keywords

4 hydroxynonenal; Malondialdehyde; Oxidative stress; Renal anemia; RhEPO

Indexed keywords

4 HYDROXYNONENAL; CYANOCOBALAMIN; FOLIC ACID; IRON; MALONALDEHYDE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HORMONAL THERAPY; HUMAN; IRON THERAPY; MALE; OXIDATIVE STRESS; PLASMA;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 0034108228     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Akubue PI, Bagchi D, Ihm WJ, Stohs SJ 1994 Excretion of malondialdehyde, formaldehyde, acetaldehyde, acetone and methyl ethyl ketone in the urine of rats given an acute dose of malondialdehyde. Toxicology 68: 338-341
2. BaudL, Ardaillou R 1986 Reactive oxygen species: production and role in the kidney. Am J Physiol 251: F765-F776
3. Bindoli A, Rigobello MP, Galzigna L 1989 Toxicity of aminochromes. Toxicol Lett 48:3-20
4. Cavdar C, Camsari T. Semin I, Gonenc S, Acikgoz O 1997 Lipid peroxidation and antioxidant activity in chronic hemodialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol 31: 371-375
5. Claster S, Chiu DT. Quintanilha A. Lubin B 1984 Neutrophils mediate lipid peroxidation in human red cells. Blood 64: 1079-1084
6. Costagliola C, RomanoL, SoriceP, DiBenedettoA 1989 Anemia and chronic renal failure: The possible role of the oxidative state of glutathione. Nephron 52: 11-14
7. Curzio M, Di Mauro C, Esterbauer H, Dianzani MU 1987 Chemotactic activity of aldehydes. Structural requirements. Role in inflammatory process. Biomed Pharmacother 41:304-314
8. Daschner M, Lenhartz H, Botticher D et al 1996 Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 50:1268-1272
9. Delmas BeawieuxMC, Combe C, Penchant E et al 1995 Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. Nephron 69: 404410
10. Eckl PM, Esterbauer H 1991 Genotoxic effects of 4-hydroxyaIkenals. Adv Biosci 76: 141-157
11. Esterbauer H, Gebicki J, Fühl H, Jürgens G 1992 The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radie Biol Med 13: 341-390
12. Geerlings W, Tufveson G, Brunner FP et al 1991 Combined report on regular dialysis and transplantation in Europe. XXI. 1990. Nephrol Dial Transplant 6 (Suppl 4): 5-29
13. Grüne T, Sommerburg O, Petras T, Siems WG 1995 Postanoxic formation of aldehydic lipid peroxidation products in human renal tubular cells. Free Radie Biol Med 75:21-27
14. HaklarG, Yegenagal, Yalcin AS 1995 Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters. Clin Chim Acta 234: 109-114
15. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS 1995 Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41: 1135-1138
16. Jiang JP, Downing SE 1990 Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med 63: 581-591
17. Kalyanaraman B, Felix CC, Sealy AC 1984 Electron spin resonance-spin stabilization of semiquinones produced during oxidation of epinephrine and its analogues. J Biol Chem 259: 354-358
18. Kikugawa K, Kosugi H, Asakura T 1984 Effect of malondialdehyde, a product of lipid peroxidation, on the function and stability of hemoglobin. Arch Biochem Biophys 229: 7-14
19. Komatsu H, Koo A, Ghadishah E el al 1992 Neutrophil accumulation in ischémie reperfused rat liver: evidence for a role for Superoxide free radicals. Am J Physiol 262: G669-G676
20. KosugiH, Kojima T, KikugawaK 1993 Characteristics of the thiobarbituric acid reactivity of human urine as a possible consequence of lipid peroxidation. Lipids 28: 337-343
21. Lewis NP, Macdougall 1C, mills N, Henderson AH 1992 The ventilatory cost of exercise compared in chronic heart failure and chronic renal anemia. Q J Med 83: 523-531
22. Linas SL, Whittenburg D, Repine JE 1990 Role of xanthine oxidase in ischemia/reperfusion injury. Am J Physiol 258: F711-F716
23. Luft R. Landau BR 1995 Mitochondrial medicine. J Int Med 255:405-421
24. Maggi E, Bellazi R, Cazo A, Seccia M, Bellomo G 1994 Autoantibodies against oxidatively-modified LDL in urémie patients undergoing dialysis. Kidney Int 46: 869-876
25. Mason Garcia M. Clejan S, Ton JS, Beckman BS 1992 Signal transduction by the erythropoietin receptor: evidence for the activation of phospholipases A2 and C. Am J Physiol 202: Cl 197-CI203
26. Nenov D, Paskalev D, Yankova T, Tchankova P 1995 Lipid peroxidation and vitamin E in red blood cells . and plasma in hemodialysis patients under rhEPO treatment. Artif Organs 19:436-439
27. Panzelta O, CominaciniL, Garbin U1995 Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis - effects of fish oil and vitamin E administration. Clin Nephrol 44: 303-309
28. Poli G, DianzaniMU. Chessman KH, Slater TF, LangJ, Esterbauer H1985 Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J 227,629-638
29. Roselaar SE. Nazhat NB. Winyard PC. Jones P, CunninghamJ. Blake DR 1995 Detection of oxidants in urémie plasma by electron spin resonance spectroscopy. Kidney Int 48: 199-206
30. SchrierRW, Harris DC, Chan L, Shapiro JI, CarameloC 1988 Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am J Kidney Dis 12: 243-249
31. +-ATPase. Free Radie Biol Med 20: 215-233
32. Sommerburg O, Grüne T, Hampl H, Riedel E, van Kuijk FJMG, Ehrich JHH, Stems WG 1998 Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol Dial Transplant 13:25832587
33. Taccone Galluci M, Lubrano R, Trapasso E et al 1994 Oxidative damage to RBC membranes and pentosephosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment. ASAIO J 40: M663-M666
34. Trachtman H. Wilson D, Rao PS 1992 The role of oxygen-free radicals in the development of chronic renal failure. Life Sei 50: 1877-1883
35. TuriS. Nemeth I, Varga l, Bodrogi T, Matkovics B 1992 The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure. Pediatr Nephrol 6: 536-541
36. Ucliida K. Stadtman ER 1993 Covalent attachment of 4-hydroxynonenal to glyceraIdehyde-3-phosphate dehydrogenase: A possible involvement of intra- and intermolecular cross-linking reaction. J Biol Chem 265: 6388-6393
37. WesthuyzenJ. Adams CE, Fleming SJ1995 Evidence for oxidative stress during in vitro dialysis. Nephron 70: 49-54
38. tl'ojcliowslci DM, He TC 1993 Signal transduction in the erythropoietin receptor system. Stem Cells 77: 381-392
39. llbng SH, Knight JA, HopferSM, Zaharia O, Leach CN Jr, Sunderman FWJr 1987 Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33:214-220
40. Zachee P, Emonds MP, Coosseiis If, Daelemans R, Lins RL, Boogaerts MA 1988 Erythrocyte deformability and oxidative sensitivity in hemodialysis patients. Clin Hemorrheol 8: 439-443